Skip to main content
Caplight Logo









Animab

Animab

Private
GentHealthcare & Life Scienceshttps://animab.com/

Last Round

Series B

Jul 1, 2025

Total Funding Raised

$25.77M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Animab is a biotechnology company that develops oral monoclonal antibody solutions to target gastrointestinal infections in production animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

oral antibodiesmonoclonal antibodiesanimal healthfeed additiveantibiotic alternativeswine healthlivestock healthpost-weaning diarrheaagritechagtechanimal biotechnologygut healthpassive immunityantibody developmentETEC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Animab Comparables

Compare Animab with similar companies based on industry and business-model similarity.

Animab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BACTOLIFE
83%
NovoBind Livestock Therapeutics Inc.
76%
ViroVet
69%

Animab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 1, 2025
Series ANov 10, 2022
SeedOct 27, 2020

Key People

Founding team and executive leadership

Alain Wille

Chief Executive Officer

Executive Team

Animab Investors

Notable investors and investment history

Animab investors
InvestorRounds
V-Bio VenturesSeries B, Series A, Seed
PMVSeries A, Series B, Seed
QBIC III FundSeries B, Series A
VIBSeries B, Series A, Seed
Seventure PartnersSeries B, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 69% MoM, from 1.1K to 1.8K.

  • May 20, 2026

    Monthly visitors grew 109% MoM, reaching 1.1K.

Animab Filings

Explore SEC and related filing metadata, where available.

Animab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Animab's valuation, stock price, and market status.

Is Animab a public or private company?

Animab is a private company.

What is the current stock price of Animab?

Animab is a private company with no public stock price. No recent secondary market data is available.

How much is Animab worth (valuation)?

Valuation information for Animab is not publicly available.

Can I buy Animab stock?

Animab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Animab's last funding round?

Animab's most recent funding round was Series B on July 1, 2025.

Who are the main investors in Animab?

Key investors in Animab include PMV, QBIC III Fund, Seventure Partners.

Will Animab IPO soon?

No public IPO plans have been announced for Animab.

How can I track Animab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Animab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGent
Employee Range14
Year Founded2020
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?